South Africa: Trade Mark Registrations For The Shape Of A Product

Last Updated: 29 August 2001
Article by Karen-Eloise Schukala
Since the current Trade Marks Act, Act no 94 of 1993 ("the Act"), came into operation on 1 May 1995, it has been possible to register a trade mark in South Africa for the shape of a product. Such a trade mark registration was recently considered by the High Court of South Africa in the matter between Triomed (Pty) Limited v Beecham Group Plc & SmithKline Beecham Pharmaceuticals.

The Applicant in the matter, Triomed (Pty) Limited, brought an urgent application to expunge the Respondents’ trade mark registration for the shape of an antibiotic tablet. The Respondents opposed the application and brought a counter-application, inter alia, for trade mark infringement and passing-off.

The Main Application

The Applicant’s case was essentially that the Respondents endeavoured, through trade mark registration, to obtain a monopoly of the most appropriate shape for the tablet in question, a shape which other pharmaceutical manufacturers or distributors were using or may reasonably want to use in the course of the pharmaceutical trade. It was alleged that the shape was incapable of distinguishing the Respondents’ pharmaceutical products from similar products in the trade. The Applicant argued that the tablet simply consists of an oval shape tablet commonly found in the pharmaceutical industry, bearing no distinguishing features or characteristics by which the public would recognise the shape of the tablet as constituting a trade mark. The Applicant further contended that the tablet shape consisted of a shape or configuration where the registration of such a mark would limit the development of any art or industry and that if registration of the tablet shape was not expunged, others would not be able to use the oval shape tablet and would be prohibited from competing effectively.

The Respondents submitted that, based on a market survey, the shape trade mark was in fact capable of distinguishing their antibiotics from those of other similar products in the market.

The Court’s Decisions

The Court found that no evidence had been forthcoming identifying the specific feature(s) of the shape which were alleged to be distinctive and disagreed with the Respondents, who sought to equate recognition and familiarity with the tablet shape with the distinctiveness of the trade mark in question.

Marks that consist exclusively of a sign or any indication that may serve, in trade, to designate kind, quality, quantity, intended purpose or other characteristics of the goods in question, are generally precluded from registration. The Court held that there was a lack of compelling evidence that the interested public, including doctors, pharmacists and patients, regard the shape of the tablet in question as being a trade mark of the Respondents and not simply as the goods themselves. In addition, it was held that the mark consisted exclusively of a sign or indication that had become customary in the bona fide and established practices of the pharmaceutical trade and that the tablet shape had been used by many other pharmaceutical manufacturers in the course of trade.

In terms of Section 10(5) of the Act, a mark is not registrable if it consists exclusively of the shape configuration of goods where such a shape is necessary to obtain a specific technical result from the nature of the goods themselves. The Respondents showed that there were various other shapes that obtain the same technical result. However, the Court held that it does not matter that the technical result may not be a consideration for all dimensions of the shape and configuration, as long as the shape itself is necessary to achieve a technical result for certain dimensions of the tablet. All that had to be shown was that the essential features of the shape were attributable only to the technical result and that the shape was necessary to obtain the technical result.

Therefore, the Court held that the shape trade mark in question was of a shape and configuration that is essentially or primarily utilitarian and superior in design, and a prohibition on copying of the shape would inhibit competition. In effect, the Respondents would be seeking to create a monopoly through trade mark law of a primarily or essentially utilitarian shape. The Court found that the recognition of the shape of the tablet per se was not a recognition of the trade mark and concluded that the tablet shape was not the trade mark, but that the trade mark in question was something wider than the tablet shape.

Respondents’ counter-claims for infringement and passing-off

In order to establish infringement in this case, the onus rested on the Respondents to establish that their registered trade mark was well known in the Republic and that use of a similar mark was likely to take unfair advantage of or be detrimental to the distinctive character or repute of the registered mark.

The Respondents argued that the shape and configuration of the tablet sold by the Applicant was identical or at least confusingly similar to its registered trade mark. In addition, the Respondents argued that the word "AUGMAXCIL", which was used in relation to the Applicant’s product, was deceptively or confusingly similar to their registered mark "AUGMENTIN", since both of these marks commenced with the prefix "AUG" followed by the letter M. The Respondents contended that the Applicant had deliberately set out to use a mark that was very closely similar to the AUGMENTIN mark for the purposes of trading on the reputation and goodwill attached to this mark.

The Court’s Decisions

The Court confirmed that comparison between the two marks should be made through the eyes of the notional consumer. In this case the notional consumer would be the medical practitioner, who prescribes the pharmaceutical product, and the pharmacist who dispenses it, and not the patient. Accordingly, the Court dismissed the notion of confusion arising among the notional consumers.

The Court held further that the Respondents had failed to establish that the AUGMAXCIL word mark was a mark similar to AUGMENTIN. The shape depicted in the shape trade mark had also not come to be regarded as a second trade mark capable by itself of distinguishing the Respondents’ antibiotics.

The Court concluded that the AUGMAXCIL word mark and the shape adopted for the AUGMAXCIL tablet could not have the effect of diluting or blurring the distinctive nature of the word or shape trade mark of AUGMENTIN, and could therefore not be considered as having taken unfair advantage or been detrimental to its repute. It was found that the goodwill, reputation and distinctiveness that AUGMENTIN might have, would remain unaffected by the Applicant’s sale of a generic version under the trade mark AUGMAXCIL.

The Court granted the main claim for expungement of the shape trade mark in question and denied the Respondents’ counter claim for infringement of the shape or word trade mark and unlawful competition claims. The matter is currently on appeal to the Supreme Court of Appeal in Bloemfontein.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions